Cargando…
Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case–Control Trial with Quetiapine
Neurological and psychiatric symptoms are consequences of substance abuse in schizophrenia and non-schizophrenia patients. The present case–control study examined changes in substance abuse/dependence, and neurological and psychiatric symptoms in substance abusers with [dual diagnosis (DD) group, n ...
Autores principales: | Zhornitsky, Simon, Stip, Emmanuel, Desfossés, Joelle, Pampoulova, Tania, Rizkallah, Élie, Rompré, Pierre-Paul, Bentaleb, Lahcen Aït, Lipp, Olivier, Chiasson, Jean-Pierre, Gendron, Alain, Potvin, Stéphane |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098726/ https://www.ncbi.nlm.nih.gov/pubmed/21629845 http://dx.doi.org/10.3389/fpsyt.2011.00022 |
Ejemplares similares
-
Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia
por: Desfossés, Joëlle, et al.
Publicado: (2012) -
Psychopathology in Substance Use Disorder Patients with and without Substance-Induced Psychosis
por: Zhornitsky, Simon, et al.
Publicado: (2015) -
Endocannabinoids and Schizophrenia
por: Desfossés, Joëlle, et al.
Publicado: (2010) -
Relationships between Brain Structure and Metabolic Changes in Schizophrenia Patients Treated with Olanzapine: A Voxel-Based Morphometric Study
por: Letourneau, Genevieve, et al.
Publicado: (2011) -
Psychiatric Consultation and Substance Use Disorders
por: Specker, Sheila, et al.
Publicado: (2009)